Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

Similar articles for PubMed (Select 16513852)

1.

Stimulant medications: how to minimize their reinforcing effects?

Volkow ND.

Am J Psychiatry. 2006 Mar;163(3):359-61. No abstract available.

PMID:
16513852
2.

Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD.

Volkow ND, Swanson JM.

Am J Psychiatry. 2003 Nov;160(11):1909-18. Review.

PMID:
14594733
4.
5.
6.

Role of dopamine in the therapeutic and reinforcing effects of methylphenidate in humans: results from imaging studies.

Volkow ND, Fowler JS, Wang GJ, Ding YS, Gatley SJ.

Eur Neuropsychopharmacol. 2002 Dec;12(6):557-66. Review.

PMID:
12468018
7.

Mechanism of action of methylphenidate: insights from PET imaging studies.

Volkow ND, Fowler JS, Wang G, Ding Y, Gatley SJ.

J Atten Disord. 2002;6 Suppl 1:S31-43.

PMID:
12685517
8.

Is there stimulant sensitivity in children?

Klein R, Mannuzza S.

J Atten Disord. 2002;6 Suppl 1:S61-3.

PMID:
12685520
9.

Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.

Pae CU.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1149-50; author reply 1151-2. Epub 2007 Apr 1. No abstract available.

PMID:
17493730
10.

Pharmacology of adult ADHD with stimulants.

Spencer TJ.

CNS Spectr. 2007 Apr;12(4 Suppl 6):8-11. No abstract available.

PMID:
17715564
11.

Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.

Leonard BE, McCartan D, White J, King DJ.

Hum Psychopharmacol. 2004 Apr;19(3):151-80. Review. No abstract available.

PMID:
15079851
12.

Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.

Lewis H, Lewis J.

Atten Defic Hyperact Disord. 2012 Mar;4(1):37-9. doi: 10.1007/s12402-012-0071-9. Epub 2012 Feb 5.

PMID:
22311620
13.

New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential.

Connor DF, Steingard RJ.

CNS Drugs. 2004;18(14):1011-30. Review.

PMID:
15584770
14.

A case report of Concerta misuse in a patient with comorbid substance use disorder and attention deficit hyperactivity disorder.

Rizkallah E, Legault L, Pampoulova T, Lévesque S, Bélanger M, Stavro K, Chiasson JP, Potvin S.

Am J Addict. 2011 Sep-Oct;20(5):478-9. doi: 10.1111/j.1521-0391.2011.00158.x. Epub 2011 Jul 18. No abstract available.

PMID:
21838849
16.

Dexmethylphenidate (Focalin) for ADHD.

[No authors listed]

Med Lett Drugs Ther. 2002 May 13;44(1130):45-6. No abstract available.

PMID:
12011757
17.

An update on attention deficit disorder.

[No authors listed]

Harv Ment Health Lett. 2004 May;20(11):4-7. No abstract available.

PMID:
15153391
18.

Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.

Kraemer M, Uekermann J, Wiltfang J, Kis B.

Clin Neuropharmacol. 2010 Jul;33(4):204-6. doi: 10.1097/WNF.0b013e3181e29174. Review.

PMID:
20571380
19.

Impact of withdrawal of Ritalin LA in the Western Cape.

Donker Fv, Riordan G, Wilmshurst J.

S Afr Med J. 2008 Aug;98(8):570. No abstract available.

PMID:
18928026
20.

Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.

Merkel RL Jr, Kuchibhatla A.

Expert Opin Drug Saf. 2009 Nov;8(6):655-68. doi: 10.1517/14740330903279956. Review.

PMID:
19785509
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk